Clinical Trial

Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 12, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to compare how different sildenafil formulations are absorbed and tolerated in healthy adult males under fed conditions. The main questions it aims to answer are: Do Hezkue and Hezkue Turbo differ in absorption compared to other commercial sildenafil products? Are there any differences in safety or tolerability between the products? Researchers will compare multiple formulations to evaluate differences in drug absorption and side effects.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-05; most recent amendment 2025-12-05.
Trial Details
NCT Number NCT07117383
Lead Sponsor Aspargo Labs, Inc
Conditions Erectile Dysfunction
Enrollment 72 participants
Start Date 2026-01
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-12-12